The Digital Capability Center New Jersey is the first in the global network to specialize in life sciences, with a focus on cell and gene therapies (CGT). CGT is the fastest growing area of therapeutics, and sustaining this innovation requires solving many operational challenges and bringing the full potential of digital technologies. The Digital Capability Center New Jersey’s work concentrates on the impact of digital enablement across CGT-related operations—economies of scale and productivity, quality excellence, and supply-chain efficiencies and resilience—and enabling a new generation of leaders in the Fourth Industrial Revolution.
This state-of-the-art learning facility helps biopharma companies to deploy digital capabilities, reimagine their operations functions beyond the four walls of a manufacturing facility, and scale the changes across workforces. It features a model cell-therapy-manufacturing facility to provide biopharma companies with an immersive learning experience that simulates the journey to operational excellence.
Learning opportunities can be tailored for individual client contexts as either one-off workshops, or extended sessions delivered over weeks or months for effective capability building that becomes part of an organization’s operating model. They include observations of a simulated manufacturing process in its before and after state, deep dives into digital use cases, and plenaries in lean principles and enabling mindsets.
The Digital Capability Center New Jersey was developed in partnership with the New Jersey Innovation Institute and is operated by BioCentriq.